Medical School
- MD, University of Michigan Medical School (2016)
Graduate School
- PhD, University of Michigan (2016)
Undergraduate School
- BS, Yale University (CT) (2008)
Residency
- University of California (San Francisco) School of Medicine Program, Chief Resident, Urology (2022)
Fellowships
- University of California (San Francisco) School of Medicine Program, Urology (2024)
Department
Surgery-UrologyRecognitions
- Research Scholar Award/Outstanding Graduate Scholar, American Urological Association (2024)
- Early Investigator Showcase, American Urological Association (2024)
- National Institute of Diabetes and Digestive and Kidney Diseases, TL1 Grant (2023)
- American Urological Association, Best Poster Award (2023)
- UCSF Clinical and Translational Science Institute, Resident Research Funding Award (2021)
-
Research Grant, California Urology Foundation
(2018)
2018-2024 - F30 Grant, National Institute of Aging (2013)
Publications
- Yang H, Song H, Yip E, Gilpatrick T, Chang K, Allegakoen P, Lu KL, Hui K, Pham JH, Kasap C, Kumar V, Gayle J, Stohr BA, Cornelia Ding CK, Wiita AP, Meng MV, Chou J, Porten SP, Huang FW. Bladder cancer variants share aggressive features including a CA125 cell state and targetable TM4SF1 expression. Nat Commun. 2025 Jun 17;16(1):5312. PubMed PMID: 40527915
- Taguchi K, Yang H, Bayne DB, Unno R, Hamamoto S, Chi T, Yasui T. New Technology in Percutaneous Nephrolithotomy: Application of Navigation System, Robotics, Artificial Intelligence, and Suction Access Sheath. Int J Urol. 2025 Jul;32(7):793-803. PubMed PMID: 40271897
- Ahmadi A, Yang H, Jen KY, Fan S, Palma I, Sageshima J, Goussous N, Roshanravan B, Perez RV. Packed Red Blood Cell and Whole Blood Perfusates during Ex Vivo Normothermic Perfusion for Assessment of High-Risk Donor Kidneys. Kidney360. 2025 Sep 1;6(9):1573-1585. PubMed PMID: 40333014
- Sui W, Yang H, Pepic L, Chang K, Shee K, Rompsaithong U, Bayne DB, Stoller ML, Chi T. Longer Preoperative Antibiotic Duration Prior to High-Risk Ureteroscopy Does Not Decrease Infectious Complications. J Endourol. 2025 Jan;39(1):34-41. PubMed PMID: 39628387
- Hosier GW, Beiko DT, Yang H, Sui W, Bayne D, Stoller ML, Chi TL. A Multicenter Randomized Controlled Trial of Ambulatory Versus Inpatient Percutaneous Nephrolithotomy. Eur Urol Focus. 2025 Oct 7. [Epub ahead of print] PubMed PMID: 41062420
- Sui W, Yang H, Velasquez MC, Stoller ML, Chi T. Re-defining the interpretation of 24-h urine studies for stone formers. BJU Int. 2025 Apr;135(4):691-699. PubMed PMID: 39846125
- Sui W, Suarez P, Yang H, Escobar MCV, Maluf FC, Hall T, Azzawi SA, Gupta L, Chi T. Financial toxicity in lower urinary tract symptoms amongst men. BMC Urol. 2025 Aug 21;25(1):213. PubMed PMID: 40841616
Practice Locations
UCHealth Urology Clinic - Anschutz Medical Campus1635 Aurora Ct
3rd Floor
Aurora, CO 80045
720-848-1800
Hospital Affiliation
- University of Colorado Hospital
- Children's Hospital Colorado
Specialty Information
Specialties- Urology
Clinical Interests
Patient-centered outcomes in stone disease, pain reduction after kidney stone surgery, genetic causes of kidney stone disease, infections associated with kidney stone disease, pathogenesis of Randall’s plaques (kidney stone precursors), kidney autotransplantation, and ureteral injury and strictures
Care Philosophy
I want to eliminate pain and suffering associated with kidney stones. My job is to help patients achieve two major goals: 1) become stone-free using the safest, most effective, and least invasive approach, and 2) remain stone-free with a multifaceted plan (diet, lifestyle, medications) tailored to the biology and preferences of each individual patient. As our understanding of stone disease evolves, I want to keep my patients informed on the latest developments in research and technology. It is also my responsibility to expose my patients to opportunities to participate in and benefit from high quality research.
Patient-centered outcomes in stone disease, pain reduction after kidney stone surgery, genetic causes of kidney stone disease, infections associated with kidney stone disease, pathogenesis of Randall’s plaques (kidney stone precursors), kidney autotransplantation, and ureteral injury and strictures
Care Philosophy
I want to eliminate pain and suffering associated with kidney stones. My job is to help patients achieve two major goals: 1) become stone-free using the safest, most effective, and least invasive approach, and 2) remain stone-free with a multifaceted plan (diet, lifestyle, medications) tailored to the biology and preferences of each individual patient. As our understanding of stone disease evolves, I want to keep my patients informed on the latest developments in research and technology. It is also my responsibility to expose my patients to opportunities to participate in and benefit from high quality research.